Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 6/20 | 0.53 |
| ▸ | CASP7 | P55210 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RGS12 | O14924 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.53 |
| ▸ | MTOR | P42345 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.53 |
| ▸ | HBB | P68871 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29372946 | 1.00 | PARP1 (0.53) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL28012033 | 0.98 | PARP1 (0.52) | PARP1CASP7MEN1RGS12USP2 | |
| Alcohol SCHEMBL11504765 | 0.89 | KDM4E (0.47) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL27277884 | 0.88 | ADORA2A (0.57) | PARP1CASP7MEN1RGS12USP2 | |
| Pyridine SCHEMBL27532836 | 0.88 | PARP1 (0.44) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL18660318 | 0.86 | PARP1 (0.45) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL7806626 | 0.86 | GSK3B (0.52) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL7599788 | 0.85 | PARP1 (0.58) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL29260788 | 0.82 | PARP1 (0.40) | PARP1CASP7MEN1RGS12USP2 | |
| SCHEMBL3988383 | 0.82 | ADORA2A (0.46) | PARP1CASP7MEN1RGS12USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118186618-B | Medical antibacterial bedding fabric and preparation process thereof | 海南洁达投资有限公司 | 2024-12-24 | — | — | CN | claimed |
| CN-119076058-A | Carbon intercalation iron phthalocyanine heterogeneous junction and preparation method and application thereof | 南京大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118320644-A | Organic solvent-resistant separation membrane and preparation method thereof | 苏州纳信膜技术有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118186618-A | Medical antibacterial bedding fabric and preparation process thereof | 海南洁达投资有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117645638-A | Fullerene derivative, and preparation method and application thereof | 中国科学院化学研究所 | 2024-03-05 | — | — | CN | claimed |
| CN-115626916-B | Pomalidomide derivative as well as preparation method and application thereof | 河南科技大学第一附属医院 | 2024-01-30 | — | — | CN | claimed |
| US-20230364243-A1 | CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2023-11-16 | — | — | US | claimed |
| CN-115636815-B | Preparation method and application of pomalidomide connected urea compound | 新乡学院 | 2023-10-27 | — | — | CN | claimed |
| CN-113929748-B | Kit for detecting BACE1 enzyme activity and application thereof | 中国科学技术大学 | 2023-10-20 | — | — | CN | claimed |
| US-11725227-B2 | Devices and methods for examining drug effects on microorganisms | ESSENLIX CORPORATION (US) | 2023-08-15 | — | — | US | claimed |
| WO-1998023690-A9 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | — | 1998-09-17 | — | — | WO | claimed |
| WO-1998023690-A1 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 1998-06-04 | — | — | WO | claimed |
| CN-1136275-A | Arylheterocyclylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics | HOECHST ROUSSEL PHARMA (US) | 1996-11-20 | — | — | CN | claimed |
| EP-0445926-B1 | Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation | MILLIKEN RES CORP (US) | 1996-08-21 | — | — | EP | claimed |
| US-5529869-A | IMPROVED ELECTRICAL CHARGE ACCEPTANCE AND CHARGE RETENTION ABILITY | HEWLETT-PACKARD COMPANY (US) | 1996-06-25 | — | — | US | claimed |
| EP-0605566-A1 | LIGHT-ABSORBING POLYURETHANE COMPOSITIONS AND THERMOPLASTIC POLYMERS COLORED THEREWITH | EASTMAN CHEMICAL COMPANY (US) | 1994-07-13 | — | — | EP | claimed |
| WO-1993006147-A1 | LIGHT-ABSORBING POLYURETHANE COMPOSITIONS AND THERMOPLASTIC POLYMERS COLORED THEREWITH | EASTMAN KODAK COMPANY (US) | 1993-04-01 | — | — | WO | claimed |
| US-4992204-A | LUMINOPHORE LINKED TO POLYALKYLENE MOIETY | MILIKEN RESEARCH CORPORATION (US) | 1991-02-12 | — | — | US | claimed |
| US-4682983-A | Transfer sheet for the thermal dry impression of cellulose fibers | SICPA HOLDING S.A. (CH) | 1987-07-28 | — | — | US | claimed |
| EP-0099333-B1 | TRANSFER SHEETS FOR THE THERMAL DRY-PRINTING OF CELLULOSIC FIBRES | SICPA HOLDING S.A. (CH) | 1986-09-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230364243-A1 | CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS | ADRM1, MYC, SKP2 | PARP1 1231/4885CASP7 2149/4885MEN1 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.